Literature DB >> 19047306

Quo vadis with targeted drugs in the 21st century?

Jonas Bergh.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19047306     DOI： 10.1200/JCO.2008.18.8342

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

Review 1.  Hurdles in anticancer drug development from a regulatory perspective.

Authors:  Bertil Jonsson; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2012-02-21       Impact factor: 66.675

Review 2.  What is the role of chemotherapy in endometrial cancer?

Authors:  Thomas Hogberg
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 4.  Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear.

Authors:  Peniel M Dimberu; Ralf M Leonhardt
Journal:  Yale J Biol Med       Date:  2011-12

5.  RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.

Authors:  José Baselga; Claudio Zamagni; Patricia Gómez; Begoña Bermejo; Shigenori E Nagai; Bohuslav Melichar; Arlene Chan; Lászlo Mángel; Jonas Bergh; Frederico Costa; Henry L Gómez; William J Gradishar; Clifford A Hudis; Bernardo L Rapoport; Henri Roché; Patricia Maeda; Liping Huang; Gerold Meinhardt; Joshua Zhang; Lee S Schwartzberg
Journal:  Clin Breast Cancer       Date:  2017-05-22       Impact factor: 3.225

6.  Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer.

Authors:  Theodoros Foukakis; John Lövrot; Patricia Sandqvist; Hanjing Xie; Linda S Lindström; Carla Giorgetti; Hans Jacobsson; Elham Hedayati; Jonas Bergh
Journal:  Mol Oncol       Date:  2015-04-03       Impact factor: 6.603

Review 7.  Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.

Authors:  Jan Stenvang; Iben Kümler; Sune Boris Nygård; David Hersi Smith; Dorte Nielsen; Nils Brünner; José M A Moreira
Journal:  Front Oncol       Date:  2013-12-25       Impact factor: 6.244

8.  Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care.

Authors:  Joanne E Mortimer; Laura Kruper; Mary Cianfrocca; Sayeh Lavasani; Sariah Liu; Niki Tank-Patel; Mina Sedrak; Wade Smith; Daphne Stewart; James Waisman; Christina Yeon; Tina Wang; Yuan Yuan
Journal:  J Clin Med       Date:  2020-06-24       Impact factor: 4.241

Review 9.  The application of photodynamic therapy in plastic and reconstructive surgery.

Authors:  Min Wu; Xiaoyu Huang; Lu Gao; Guoyu Zhou; Feng Xie
Journal:  Front Chem       Date:  2022-07-22       Impact factor: 5.545

10.  Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model.

Authors:  Roberto Canaparo; Greta Varchi; Marco Ballestri; Federica Foglietta; Giovanna Sotgiu; Andrea Guerrini; Andrea Francovich; Pierluigi Civera; Roberto Frairia; Loredana Serpe
Journal:  Int J Nanomedicine       Date:  2013-11-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.